Skip to main content

Advertisement

SpringerLink
Log in

Timing is important in medication administration: a timely review of chronotherapy research

  • Review Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Chronotherapy involves altering the timing of medication administration to improve the overall control of a disease and to minimise treatment side-effects, and is an emerging concept in the field of therapeutics. Aim The aim of this review is to conduct an in-depth analysis of the recent literature in order to identify and evaluate the evidence base for drug chronotherapy. Method A literature search was conducted in three databases (Medline, Embase, International Pharmaceutical Abstracts) using the search terms “Chronotherapy”, “Chronopharmacology”, “Chronopharmacokinetics”, “Chronopharmacodynamics”, “Chronoefficacy”, “Chronoformulation”, “Morning and Evening”, “Morning and Bedtime” and their combinations. The selection criteria for the inclusion of articles in the review included currency (years 2008–Aug 2011), publication in English language, studies done in Humans and non-review articles that pertained to ‘drug’ therapy. Results Our search revealed a total of 192 journal articles, of which 41 articles were selected for review. The specific hypothesis for the effectiveness of chronotherapy that was tested in these 41 studies was chronoeffectiveness (n = 34), followed by chronopharmacokinetics (n = 5), chronomodulation (n = 3) and chronopharmacodynamics (n = 2). The findings from two-thirds (n = 27) of the reviewed studies, support the notion of chronotherapy. Conclusion The review presents the scope of chronotherapy in drug utilization. We believe that the knowledge of chronotherapy is growing and the current research for chronotherapy is promisingly in the conceptualization or early experimental phase. Going forward, chronotherapy studies should also explore genetic, gender and age related differences. Preliminary screening of new drugs for chronotherapeutic potential may be a way of enhancing quality use of medicines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lemmer B, Labrecque G. Chronopharmacology and chronotherapeutics: definitions and concepts. Chronobiol Int. 1987;4(3):319–29.

    Article  PubMed  CAS  Google Scholar 

  2. Smolensky MH. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens. 1996;9(4 Pt 3):11S–21S.

    PubMed  CAS  Google Scholar 

  3. Lemmer B. Relevance for chronopharmacology in practical medicine. Semin Perinatol. 2000;24(4):280–90.

    Article  PubMed  CAS  Google Scholar 

  4. Touitou Y, Haus E. Biologic rhythms in clinical and laboratory medicine. Special ed. Berlin: Springer; 1994.

    Google Scholar 

  5. Lemmer B. The clinical relevance of chronopharmacology in therapeutics. Pharmacol Res. 1996;33(2):107–15.

    Article  PubMed  CAS  Google Scholar 

  6. Sobrino J, Casanas L, Izquierdo C, Clavell J. Circadian rhythm variability in arterial blood pressure. Rev Enferm. 2006;29(6):50–2.

    PubMed  Google Scholar 

  7. Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007;59(9–10):852–82.

    Article  PubMed  CAS  Google Scholar 

  8. Harkness JA, Richter MB, Panayi GS, Pette KVD, Unger A, Pownall R, et al. Circadian variation in disease activity in rheumatoid arthritis. BMJ. 1982;284(6315):551–4.

    Article  PubMed  CAS  Google Scholar 

  9. Bellamy N, Sothern RB, Campbell J, Buchanan WW. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis. 2002;61(12):1075–80.

    Article  PubMed  CAS  Google Scholar 

  10. Quyyumi AA. Circadian rhythms in cardiovascular disease. Am Heart J. 1990;120(3):726–33.

    Article  PubMed  CAS  Google Scholar 

  11. Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol. 1995;95(5 Pt 2):1084–96.

    Article  PubMed  CAS  Google Scholar 

  12. Mormont MC, Lévi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70(2):241–7.

    Article  PubMed  CAS  Google Scholar 

  13. Hart FD, Taylor RT, Huskisson EC. Pain at night. Lancet. 1970;1(7652):881–4.

    Article  PubMed  CAS  Google Scholar 

  14. Björn L. Circadian rhythms and drug delivery. J Control Release. 1991;16(1–2):63–74.

    Google Scholar 

  15. Reinberg A, Smolensky MH. Circadian changes of drug disposition in man. Clin Pharmacokinet. 1982;7(5):401–20.

    Article  PubMed  CAS  Google Scholar 

  16. Scott Md AJ, LaDou J. Biological rhythms, shiftwork, and occupational health. In: Bingham E, Cohrssen B, Powell CH, editors. Patty’s toxicology. New York: Wiley; 2001.

  17. Reinberg A. Recent advances in chronobiology. Acta Med Auxol. 1976;8(2):135–146.

    Google Scholar 

  18. Smolensky MH, D’Alonzo GE. Biologic rhythms and medicine. Am J Med. 1988;85(1B):34–46.

    Article  PubMed  CAS  Google Scholar 

  19. Reinberg AE. Concepts in chronopharmacology. Annu Rev Pharmacol Toxicol. 1992;32:51–66.

    Article  PubMed  CAS  Google Scholar 

  20. Reinberg A. New aspects of human chronopharmacology. Arch Toxicol. 1976;36(3–4):327–39.

    Article  PubMed  CAS  Google Scholar 

  21. Ohdo S. Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety. Drug Saf. 2003;26(14):999–1010.

    Article  PubMed  CAS  Google Scholar 

  22. Smolensky MH, Hermida RC, Haus E, Portaluppi F, Reinberg A. Biological rhythms, medication safety, and women’s health. J Womens Health (Larchmt). 2005;14(1):38–46.

    Article  Google Scholar 

  23. Sewlall S, Pillay V, Danckwerts MP, Choonara YE, Ndesendo VM, du Toit LC. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv. 2010;7(5):370–88.

    Article  PubMed  CAS  Google Scholar 

  24. Smolensky MH, D’Alonzo GE. Investigative protocols for chronotherapeutics. Basic requirements and illustrative case histories. Ann N Y Acad Sci. 1991;618:465–83.

    Article  PubMed  CAS  Google Scholar 

  25. Ohdo S. Chronopharmacology focused on biological clock. Drug Metab Pharmacokinet. 2007;22(1):3–14.

    Article  PubMed  CAS  Google Scholar 

  26. Reinberg AE. Concepts of circadian chronopharmacology. Ann N Y Acad Sci. 1991;618:102–15.

    Article  PubMed  CAS  Google Scholar 

  27. Bruguerolle B, Philip-joet F, Parrel M, Arnaud A. Unequal twice-daily, sustained-release theophylline dosing in chronic obstructive pulmonary disease. Chronobiol Int. 1987;4(3):381–5.

    Article  PubMed  CAS  Google Scholar 

  28. Hassan A, Haefeli WE. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci. 2010;32(2):162–71.

    Article  PubMed  Google Scholar 

  29. Alten R, Doring G, Cutolo M, Gromnica-Ihle E, Witte S, Straub R, et al. Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with night time-release prednisone. J Rheumatol. 2010;37(10):2025–31.

    Article  PubMed  Google Scholar 

  30. Asmar R, Gosse P, Quere S, Achouba A. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine. Blood Press Monit. 2011;16(2):80–6.

    Article  PubMed  Google Scholar 

  31. Bethke TD, Huennemeyer A, Lahu G, Lemmer B. Chronopharmacology of roflumilast: a comparative pharmacokinetic study of morning versus evening administration in healthy adults. Chronobiol Int. 2010;27(9–10):1843–53.

    Article  PubMed  CAS  Google Scholar 

  32. Glass-Marmor L, Paperna T, Galboiz Y, Miller A. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J Neuroimmunol. 2009;210(1–2):124–7.

    Article  PubMed  CAS  Google Scholar 

  33. Lee RD, Mulford D, Wu J, Atkinson SN. The effect of time-of-day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR: evidence for dosing flexibility with a dual delayed release proton pump inhibitor. Aliment Pharmacol Ther. 2010;31(9):1001–11.

    PubMed  CAS  Google Scholar 

  34. Magnussen H, Verkindre C, Jack D, Jadayel D, Henley M, Woessner R, et al. Indacaterol once-daily is equally effective dosed in the evening or morning in COPD. Respir Med. 2010;104(12):1869–76.

    Article  PubMed  CAS  Google Scholar 

  35. Malhotra BK, Crownover PH, LaBadie R, Glue P, MacDiarmid SA. The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing. Eur J Clin Pharmacol. 2010;66(2):171–6.

    Article  PubMed  CAS  Google Scholar 

  36. Qvortrup C, Jensen BV, Fokstuen T, Nielsen SE, Keldsen N, Glimelius B, et al. A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer. Ann Oncol. 2010;21(1):87–91.

    Article  PubMed  CAS  Google Scholar 

  37. Suic SP, Laus KN, Dosen VM, Ekert M, Mandic Z, Bojic L. Comparison of evening and morning dosing of travoprost 0.004 %/timolol 0.5 % fixed combination in 6 month Period. Coll Antropol. 2010;34(3):847–52.

    PubMed  CAS  Google Scholar 

  38. Suzuki K, Aizawa Y. Evaluation of dosing time-related anti-hypertensive efficacy of valsartan in patients with type 2 diabetes. Clin Exp Hypertens. 2011;33(1):56–62.

    Article  PubMed  CAS  Google Scholar 

  39. He YL, Valencia J, Zhang Y, Schwartz SL, Ligueros-Saylan M, Foley J, et al. Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes. Br J Clin Pharmacol. 2010;70(1):34–42.

    Article  PubMed  CAS  Google Scholar 

  40. Warnke A, Schug B, Vanderbist F, Blume H. Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chronopharmacologically optimized treatment of pain from various sources. Int J Clin Pharmacol Ther. 2009;47(6):405–12.

    PubMed  CAS  Google Scholar 

  41. Yoon HS, Kim SH, Kim JK, Ko SH, Ko JE, Park SJ, et al. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia. Ann Pharmacother. 2011;45(7–8):841–9.

    Article  PubMed  CAS  Google Scholar 

  42. Zetterstrom O, Dahl R, Lindqvist A, Olsson P. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler. Respir Med. 2008;102(10):1406–11.

    Article  PubMed  CAS  Google Scholar 

  43. Ayala DE, Hermida RC. Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 2010;27(2):345–62.

    Article  PubMed  CAS  Google Scholar 

  44. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am J Hypertens. 2009;22(8):896–903.

    Article  PubMed  CAS  Google Scholar 

  45. Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JGP, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996–2003.

    Article  PubMed  CAS  Google Scholar 

  46. Hermida RC, Ayala DE, Mojon A, Chayan L, Dominguez MJ, Fontao MJ, et al. Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol Int. 2008;25(6):950–70.

    Article  PubMed  CAS  Google Scholar 

  47. Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54(1):40–6.

    Article  PubMed  CAS  Google Scholar 

  48. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens. 2008;21(8):948–54.

    Article  PubMed  CAS  Google Scholar 

  49. Hermida RC, Ayala DE, Mojon A, Alonso I, Fernandez JR. Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension. Blood Press Monit. 2009;14(4):152–9.

    Article  PubMed  Google Scholar 

  50. Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int. 2009;26(1):61–79.

    Article  PubMed  CAS  Google Scholar 

  51. Povedano ST, Garcia De La Villa B. 24-h and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan. J Clin Hypertens. 2009;11(8):426–31.

    Article  CAS  Google Scholar 

  52. Hermida RC, Ayala DE, Fontao MJ, Mojon A, Fernandez JR. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int. 2010;27(6):1287–303.

    Article  PubMed  CAS  Google Scholar 

  53. Hoshino A, Nakamura T, Matsubara H. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens. 2010;32(7):416–22.

    Article  PubMed  CAS  Google Scholar 

  54. Meng Y, Zhang Z, Liang X, Wu C, Qi G. Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiol. 2010;65(3):309–14.

    Article  PubMed  Google Scholar 

  55. Zeng J, Jia M, Ran H, Tang H, Zhang Y, Zhang J, et al. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing a multicenter, open-label randomized study. Hypertens Res. 2011;34(6):767–72.

    Article  PubMed  CAS  Google Scholar 

  56. Konstas AG, Hollo G, Mikropoulos D, Tsironi S, Haidich AB, Embeslidis T, et al. Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma. Br J Ophthalmol. 2010;94(2):209–13.

    Article  PubMed  Google Scholar 

  57. Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann Rheum Dis. 2010;69(7):1275–80.

    Article  PubMed  CAS  Google Scholar 

  58. Takmaz T, Asik S, Kurkcuoglu P, Gurdal C, Can I. Comparison of intraocular pressure lowering effect of once daily morning vs evening dosing of latanoprost/timolol maleate combination. Eur J Ophthalmol. 2008;18(1):60–5.

    PubMed  CAS  Google Scholar 

  59. Tharavanij T, Wongtanakarn S, Lerdvuthisopon N, Teeraaunkul S, Youngsriphithak P, Sritipsukho P. Lipid lowering efficacy between morning and evening simvastatin treatment: a randomized double-blind study. J Med Assoc Thail. 2010;93(Suppl 7):S109–13.

    Google Scholar 

  60. Okeahialam B, Ohihoin E, Ajuluchukwu J. Chronotherapy in Nigerian hypertensives. Ther Adv Cardiovasc Dis. 2011;5(2):113–8.

    Article  PubMed  Google Scholar 

  61. Almeida L, Loureiro AI, Vaz-Da-Silva M, Torrao L, Maia J, Fernandes-Lopes C, et al. Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor. Curr Med Res Opin. 2010;26(5):1097–108.

    Article  PubMed  CAS  Google Scholar 

  62. Smolensky MH. Compliance to prescription medications entails respect for treatment timing. Chronobiol Int. 2002;19(2):502–5.

    PubMed  Google Scholar 

  63. Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):828–51.

    Article  PubMed  CAS  Google Scholar 

  64. Kraft M, Martin RJ. Chronobiology and chronotherapy in medicine. Dis Mon. 1995;41(8):501–75.

    Article  Google Scholar 

  65. Prins JM, Weverling GJ, van Ketel RJ, Speelman P. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients. Clin Pharmacol Ther. 1997;62(1):106–11.

    Article  PubMed  CAS  Google Scholar 

  66. Ohdo S, Wang DS, Koyanagi S, Takane H, Inoue K, Aramaki H, et al. Basis for dosing time-dependent changes in the antiviral activity of interferon-alpha in mice. J Pharmacol Exp Ther. 2000;294(2):488–93.

    PubMed  CAS  Google Scholar 

  67. Lund TM, Torsvik H, Falch D, Christophersen B, Skardal R, Gullestad L. Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease. Am J Cardiol. 2002;90(7):784–6.

    Article  PubMed  CAS  Google Scholar 

  68. Qureshi J, Amir M, Ahuja A, Baboota S, Ali J. Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma. Indian J Pharm Sci. 2008;70(3):351–6.

    Article  PubMed  CAS  Google Scholar 

  69. Balan H. Bedtime versus at awakening administration of BP lowering drugs—is it the way to success? Rom J Intern Med. 2009;47(4):355–61.

    PubMed  CAS  Google Scholar 

  70. Hermida RC, Ayala DE, Fontao MJ, Mojon A, Alonso I, Fernandez JR. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int. 2010;27(3):560–74.

    Article  PubMed  CAS  Google Scholar 

  71. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 2011;34(6):1270–6.

    Article  PubMed  Google Scholar 

  72. Hermida RC, Ayala DE, Fernandez JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension. 2008;51(1):69–76.

    Article  PubMed  CAS  Google Scholar 

  73. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am J Hypertens. 2010;23(4):432–9.

    Article  PubMed  CAS  Google Scholar 

  74. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27(8):1629–51.

    Article  PubMed  Google Scholar 

  75. Pizzuto M, Portelli J, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM. Chronopharmacology of antihypertensives. J Appl Ther Res. 2010;7(4):133–40.

    CAS  Google Scholar 

  76. To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y, et al. Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int. 2011;28(3):267–74.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the Faculty of Pharmacy, University of Sydney and the Woolcock Institute of Medical Research for providing infrastructure support.

Funding

None.

Conflicts of interest

Authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Room S114, Pharmacy and Bank Building A15, Faculty of Pharmacy, University of Sydney, Science Road, Camperdown, NSW, 2006, Australia

    Gagandeep Kaur

  2. Woolcock Institute of Medical Research, Missenden Road, PO Box M77, Camperdown, NSW, 2050, Australia

    Craig Phillips & Keith Wong

  3. Room S303, Pharmacy and Bank Building A15, Faculty of Pharmacy, University of Sydney, Science Road, Camperdown, NSW, 2006, Australia

    Bandana Saini

Authors
  1. Gagandeep Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Craig Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keith Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bandana Saini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gagandeep Kaur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaur, G., Phillips, C., Wong, K. et al. Timing is important in medication administration: a timely review of chronotherapy research. Int J Clin Pharm 35, 344–358 (2013). https://doi.org/10.1007/s11096-013-9749-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-013-9749-0

Keywords

Search

Navigation